Introduction
Apoptosis is an active cell suicide program characterized by morphological changes including membrane blebbing, cytoplasmic fragmentation, condensation of the nucleoplasm and degradation of chromosomal DNA at internucleosomal intervals. Apoptosis plays a fundamental role in animal development and in maintaining tissue homeostasis, and is therefore tightly regulated by both proapoptotic and antiapoptotic signals (White, 1996; Vaux and Strasser, 1996) .
Initiation of apoptosis can be induced by the absence of incoming survival signals from the environment or signaled directly as a result of cell injury or through cytokine-mediated pathways. TGF-b, an extracellular polypeptide important in growth control, development and dierentiation (Derynck, 1994; Kingsley, 1994; MassagueÂ et al., 1994) , has recently been reported to play a role in apoptosis (Fan et al., 1996; Fukuda et al., 1993; Lin and Chou, 1992; Oberhammer et al., 1992; SaÂ nchez et al., 1996; Selvakumaran et al., 1994; Wang et al., 1995) . TGF-b induces apoptosis in a number of cell types including hepatocytes and several hepatoma cells (Fan et al., 1996; Fukuda et al., 1993; Lin and Chou, 1992; Oberhammer et al., 1992; SaÂ nchez et al., 1996) as well as in regressing liver in vivo (Oberhammer et al., 1992) . Furthermore, overexpession of Smad4, a signal transducer mediating various cellular responses of the TGF-b family, causes MDCK cells to undergo apoptosis . Mechanisms by which TGF-b exerts its apoptotic eect are still poorly understood. Caspase-3 and perhaps other caspase family members are activated in response to TGF-b treatment of hepatocytes and hepatoma cells (Chen and Chang, 1997; Inayat-Hussain et al., 1997) . TGF-binduced apoptosis correlates with its ability of induction of oxygen intermediates and can be partially blocked by radical scavengers, indicating the involvement of an oxidative process in this apoptosis (SaÂ nchez et al., 1996) . Overexpression of Bcl-2 blocks the apoptotic eect but does not suppress the antiproliferative activity of TGF-b suggesting that the two cellular events are mediated by divergent pathways (Selvakumaran et al., 1994) . In addition, inhibition of pRb expression was also implicated as one of the mechanisms of TGF-b-induced apoptosis (Fan et al., 1996) .
The apoptotic eect of TGF-b in the human hepatoma cells, Hep3B, can be inhibited by treatment of insulin (Chen and Chang, 1997; Chuang et al., 1994) or by an overexpression of IRS-1 (Tanaka and Wands, 1996) . These suggest a survival signal, which counteracts the apoptotic signal of TGF-b is induced by insulin through the function of IRS-1. However, it remains largely unclear how this survival signal can prevent TGF-b-induced apoptosis. Overexpression of IRS-1 in Hep3B cells causes a constitutive activation of both MAP kinase and PI 3-kinase (Tanaka and Wands, 1996) . Either of the two molecules has been reported to function against apoptosis under certain circumstances. Activation of Ras/Raf-1/MAP kinase pathway is involved in protecting hematopoietic cells from apoptotic death induced by cytokine withdrawal (Chao et al., 1997; Kinoshita et al., 1995; Leverrier et al., 1997) and activation of MAP kinase prevents neuronal cell death induced by depletion of nerve growth factor (NGF) (Xia et al., 1995) . PI 3-kinase suppresses apoptotic cell death induced by a variety of stimuli through its downstream eector ± Akt (Ahmed et al., 1997; Dudek et al., 1997; Kaumann-Zeh et al., 1997; Kennedy et al., 1997; Khwaja et al., 1997; Kulik et al., 1997) . Recently, Akt has been shown to phosphorylate Bad, thereby promoting survival del Peso et al., 1997) .
In this report, we investigated which signaling pathway transduced by insulin is responsible for the blockage of apoptotic activity of TGF-b and how this survival signal counteracts the apoptotic signal transduced by TGF-b. We provided evidence that the Ras/MAP kinase pathway conferred a mitogenic but not antiapoptotic eect in Hep3B cells, whereas both PI 3-kinase and Akt were capable of protecting against TGF-b-induced apoptosis. Activation of the PI 3-kinase/Akt pathway completely blocked the TGF-binduced caspase-3-like activity, but did not aect the TGF-b-dependent formation and nuclear accumulation of Smad3/Smad4 heterocomplex. Our results thus suggest the PI 3-kinase/Akt pathway inhibits TGF-binduced apoptosis by targeting to a step downstream of Smad and upstream of caspase activation.
Results

Ras/MAP kinase pathway transduces a mitogenic but not antiapoptotic signal
To determine whether activation of Ras can protect cells from TGF-b-induced apoptosis, Hep3B cells were transfected with an expression vector for v-H-Ras and the neomycin resistance gene (pZip-v-H-Ras). Individual G418 resistant clones were picked and assayed for the expression of the constitutively active form of Ras. Figure 1a shows the expression levels of Ras in seven stable transfectants. We chose two stable lines (v-Ras-3 and v-Ras-4) as well as a mixture of all seven clones (vRas-M) for the analysis of TGF-b-induced apoptosis. The susceptibility of these Ras stable transfectants to TGF-b-induced apoptosis was comparable to that of parental Hep3B cells, as determined by TUNEL assays (Figure 1b) as well as Cell-Death Detection ELISA assays measuring the presence of soluble histone-DNA complex resulted from DNA fragmentation ( Figure  1c) . Thus, constitutive activation of Ras did not protect cells from apoptosis induced by TGF-b. To determine whether expression of v-H-Ras has any biological eect, we measured DNA synthesis in these transfectants under serum-starved conditions. As shown in Figure 1d To further determine the role of Ras/Raf-1/MAP kinase pathway in preventing TGF-b-induced apoptosis, we blocked this pathway using a chemical agent, PD98059, which is a highly speci®c inhibitor of MEK (Alessi et al., 1995) . When Hep3B cells were simultaneously incubated with TGF-b, insulin and PD98059, PD98059 did not override the ability of insulin to protect apoptosis elicited by TGF-b even at a concentration as high as 50 mM (Figure 2 ). Taken together, our results strongly suggest that activation of Ras/Raf-1/MAP kinase pathway is not sucient to confer a survival signal, and thus the eect of insulin on TGF-b-induced apoptosis is likely to be mediated through a Ras/Raf-1/MAP kinase-independent pathway.
Activation of PI 3-kinase is both sucient and necessary for protecting cells from apoptosis induced by TGF-b
We next tested whether PI 3-kinase mediates the antiapoptotic eect of insulin. LY294002 (Vlahos et al., 1994) , a selective inhibitor of PI 3-kinase, was used to evaluate its eect on the antiapoptotic activity of insulin. As shown in Figure 3a , LY294002 inhibited the protective eect of insulin on TGF-b-induced apoptosis in a dose-dependent manner. At a dose of 25 mM, LY294002 completely blocked the antiapoptotic eect of insulin. However, LY294002 did not by itself induce apoptosis in the absence of TGF-b nor did it aect TGF-b-induced apoptosis in the absence of insulin (Figure 3a) . Our data thus indicate that inactivation of PI 3-kinase abrogates the protective eect of insulin on TGF-b-induced apoptosis.
To further evaluate the role of PI 3-kinase in the TGF-b-induced apoptosis, we tested whether such apoptosis can be suppressed by a constitutively active PI 3-kinase (p110*), in which the iSH2 domain of the regulatory subunit is fused to the catalytic subunit of the kinase (Hu et al., 1995) . Hep3B cells were cotransfected with expression vectors for p110* and the neomycin resistance gene and the G418 resistant clones were selected. The expression levels of the active and endogenous PI 3-kinases in six stable lines were determined by Western blot with an antibody to the catalytic subunit of the kinase. A high expressor (p110*-4), a low expressor (p110*-6) and a mixture of all six clones (p110*-M) were used to analyse their responses to TGF-b. Expression of the constitutively active PI 3-kinase eciently inhibited TGF-b-induced apoptosis, and the degree of protection correlated with the expression level of the active PI 3-kinase ( Figure  3c ). These results indicate that insulin inhibits TGF-binduced apoptosis through a PI 3-kinase-dependent pathway.
Akt, but not p70 S6 kinase, is a downstream target of the antiapoptotic signal transmitted from PI 3-kinase
The serine/threonine protein kinase Akt is a downstream eector of PI 3-kinase and has been reported to elicit antiapoptotic eect against a number of stimuli (Ahmed et al., 1997; Dudek et al., 1997; KaumannZeh et al., 1997; Kennedy et al., 1997; Khwaja et al., 1997; Kulik et al., 1997) . To assess whether the activation of Akt is sucient to protect cells from TGF-b-induced apoptosis, we utilized an activated form of Akt (MyrAkt), in which the Src myristoylation signal was fused to its N-terminus (Kulik et al., 1997) . Several stable transfectants expressing the MyrAkt were generated and their expression levels shown in Figure 4a . The susceptibility of these cells to TGF-b-induced apoptosis was then tested. Activation of MyrAkt by targeting the enzyme to the membrane was sucient to protect cells from apoptosis induced by TGF-b (Figure 4b ). To further con®rm the importance of Akt in the suppression of TGF-binduced apoptosis, we generated stable transfectants expressing a kinase-defective Akt (Akt K179A) (Kulik et al., 1997) , which has been demonstrated to inactivate wild type Akt in a dominant-negative fashion (Kohn et al., 1995) . Figure 4c shows the expression levels of the kinase-defective Akt in eight stable lines. Using a high expressor, Akt(K In addition to Akt, we also tested the involvement of p70 S6 kinase, another downstream signaling molecule of PI 3-kinase (Chou and Blenis, 1995) , in the antiapoptotic response induced by insulin. As shown in Figure 5 , when Hep3B cells were simultaneously treated with TGF-b, insulin and rapamycin, an inhibitor of p70 S6 kinase (Chung et al., 1992) , rapamycin did not suppress the antiapoptotic eect of insulin on TGF-b-induced apoptosis, indicating that the p70 S6 kinase may not be relevant in the protective eects mediated by PI 3-kinase/Akt. To investigate whether activation of PI 3-kinase inhibits the nuclear translocation of Smad3 and Smad4, parental Hep3B cells or the stable transfectants expressing the active PI 3-kinase (p110*-M) were transiently co-transfected with the two TGF-b receptors as well as the myc-tagged Smad3 and the Flagtagged Smad4. Subcellular localization of Smads were assessed by immuno¯uorescent analyses with anti-myc or anti-Flag antibody followed by nuclear staining with Hoechst 33258. As illustrated in Figure 6b in the absence of TGF-b, the Flag-tagged Smad4 was localized throughout the transfected Hep3B cells, whereas stimulation of TGF-b for 1 h induced a signi®cant nuclear accumulation of Smad4. Such nuclear translocation was also observed in Hep3B cells expressing the active PI 3-kinase (p110*-M). Similar results were obtained by using the anti-myc antibody to examine the subcellular localization of Smad3 (data not shown). We thus conclude that activation of PI 3-kinase does not in¯uence the nuclear translocation of Smads in response to TGF-b.
Activation of PI 3-kinase/Akt pathway blocks TGF-b-induced activation of caspase-3
We showed previously that treatment of Hep3B cells with TGF-b induces a caspase-3-like activity (Chen and Chang, 1997) . To determine whether such activity is blocked by the activation of PI 3-kinase/Akt pathway, parental Hep3B as well as Hep3B cells stably expressing the activated PI 3-kinase (p110*-M) and Akt (MyrAkt-M) were exposed to TGF-b for various times and the cell extracts were analysed for caspase-3 activity by measuring the cleavage of ā uorogenic substrate, Ac-DEVD-AMC. As shown in Figure 7 , TGF-b-induced caspase-3-like activity was completely blocked in Hep3B cells stably expressing the active PI 3-kinase or Akt, suggesting that PI 3-kinase/Akt inhibits a step leading to the activation of caspase-3.
Discussion
The extracellular polypeptide TGF-b not only modulates cell proliferation and dierentiation but also induces apoptotic death of many cell types (Fan et al., 1996; Fukuda et al., 1993; Lin and Chou, 1992; Oberhammer et al., 1992; SaÂ nchez et al., 1996; Selvakumaran et al., 1994; Wang et al., 1995) . Molecular mechanisms by which TGF-b induces apoptosis in these cells are still poorly understood. Previous studies suggested that production of reactive oxygen intermediates and activation of caspase-family proteases (Chen and Chang, 1997; Inayat-Hussain et al., 1997) are involved in TGF-binduced apoptosis; whereas supplement of insulin or overexpression of IRS-1 inhibits such apoptotic cell death (Chen and Chang, 1997; Chuang et al., 1994; Tanaka and Wands, 1996) . In this report, we investigated which signaling pathway transduced by insulin is responsible for protecting TGF-b-induced apoptosis. We provided evidence showing that the Ras/ Raf-1/MAP kinase pathway, although mitogenic, plays no signi®cant role in promoting survival upon TGF-b treatment. In contrast, the PI 3-kinase/Akt pathway is both sucient and necessary for mediating the antiapoptotic eect of insulin.
In hematopoietic cells, Ras pathway has been shown to mediate the survival signal transduced by certain cytokines, such as IL-3 and GM-CSF (Chao et Kinoshita et al., 1995; Leverrier et al., 1997) . ERK1 and ERK2, two downstream signaling molecules of Ras, play an important role in protecting PC12 cells from apoptosis induced by NGF depletion (Xia et al., 1995) and hematopoietic cells from ceramide-induced cell death (Cuvillier et al., 1996) . Furthermore, Ras, through the action of PI 3-kinase/ Akt, inhibits cell death caused by detachment from the extracellular matrix (Khwaja et al., 1997) . However, in the system reported here, Ras/MAP kinase pathway did not confer any signi®cant role in protecting or promoting apoptosis. The oncogenic v-H-Ras did strongly stimulate cell proliferation, indicating that it is functionally active in Hep3B cells. Our ®nding is consistent with recent reports that Ras/MAP kinase cannot protect ®broblasts from apoptosis induced by UV irradiation (Kulik et al., 1997) and c-myc overexpression (Kaumann-Zeh et al., 1997; Kennedy et al., 1997) . Since the function of Ras is transduced through several downstream eectors, the net outcome of its activation is dictated by the combinatorial interactions of each eector pathway, and therefore, would be greatly in¯uenced by cell context. Indeed, recent studies demonstrated that Ras can trigger both apoptotic and anti-apoptotic pathways, through the function of MAP kinase and PI 3-kinase, respectively (Kaumann-Zeh et al., 1997). Another possible explanation for these discrepancies is that the antiapoptotic ability of Ras and MAP kinase is speci®c for certain apoptotic inducers. In this context, it would be important to investigate the mechanism by which Ras/MAP kinase pathway promotes survival.
Using a constitutively active mutant and a selective inhibitor, we demonstrated the role of PI 3-kinase in protecting TGF-b-induced apoptosis. The highly selective PI 3-kinase inhibitor, LY294002 (Vlahos et al., 1994) , conferred a 450% inhibition of the antiapoptotic eect of insulin at a concentration of 5 mM, which is close to its IC 50 (1.4 mM) tested in vitro (Vlahos et al., 1994) . Furthermore, a stable transfectant (p110*-6), expressing the active PI 3-kinase at a level comparable to the endogenous level, eectively suppressed TGF-b-induced apoptosis. These results suggest that the inhibitory eect of insulin on TGFb-induced apoptosis is mainly mediated by the PI 3-kinase pathway. We also demonstrated that PI 3-kinase transduces such antiapoptotic signal through the action of Akt. The constitutively active mutant of Akt was capable of protecting cells from apoptosis upon TGF-b stimulation, whereas its dominant negative mutant partially blocked the antiapoptotic eect of insulin. In contrast to Akt, the p70 S6 kinase is unlikely to be involved in the antiapoptotic function, because its selective inhibitor, rapamycin, had no eect on the protection of insulin even at a dose of 50 nM, which is about 1000-fold higher than its IC 50 (Chou and Blenis, 1995) . Our results are in agreement with several recent reports that Akt, but not p70 S6 kinase, serves as an antiapoptotic target of PI 3-kinase (Kulik et al., 1997; del Peso et al., 1997) .
How does the PI 3-kinase/Akt pathway interfere with the apoptotic signaling of TGF-b? The signaling pathway of bone morphogenetic proteins (BMP), a TGF-b family member, can be blocked by MAP kinase through its action on Smad1. Phosphorylation of Smad1 by MAP kinase, although does not aect its association with Smad4, inhibits its nuclear translocation in response to BMP (Kretzschmer et al., 1997) . However, in TGF-b-induced apoptosis, we found activated PI 3-kinase did not aect TGF-b-dependent formation or nuclear accumulation of Smad heterocomplex, suggesting that the target of PI 3-kinase pathway lies downstream of Smad. Interestingly, a slightly larger fraction of Smads undergoes complex formation either in the absence or presence of TGF-b in cells expressing the active PI 3-kinase than in parental Hep3B cells. The TGF-b-independent heterooligomerization of Smads is presumably due to constitutive activation of TGF-b-receptors in cells overexpressing such receptors. However, in parental Hep3B cells, this constitutive activation of Smads may lead to apoptotic cell death, which is likely to account for the lack of Smad association detected in parental Hep3B cells without TGF-b stimulation. Indeed, by immuno¯uorescent staining of Hep3B cells cotransfected with the Smad3, Smad4 and the two TGF-b receptor constructs, we observed a small portion of cells expressing Smad displayed morphological characteristics of apoptosis (data not shown). It is not surprising, however, that we can detect Smad association in Hep3B cells stimulated with TGF-b since the cells were harvested 1 h after TGF-b exposure, which is at least 6 ± 8 h prior to the onset of apoptosis (Chen and Chang, 1997) .
Previous studies indicated that activation of caspasefamily proteases is involved in TGF-b-induced apoptosis (Chen and Chang, 1997; Inayat-Hussain et al., 1997) . Our studies suggest that PI 3-kinase/Akt pathway suppresses the apoptotic signaling of TGF-b by blocking its induction of caspase-3-like activity. Whether PI 3-kinase/Akt pathway directly inhibits the activation of caspase-3 or abrogates a step upstream of caspase activation in our system is presently unknown. Akt has recently been shown to be capable of phosphorylation of Bad on a serine residue (del Peso et al., 1997; Datta et al., 1997) , thereby preventing Bad from association with Bcl-X L . Bcl-X L is then free to resume its activity as a suppressor of apoptosis (Zha et al., 1996) . It is likely that PI 3-kinase/Akt pathway protects Hep3B cells from apoptotic death induced by TGF-b through such mechanism.
Failure to positively regulate apoptosis has emerged as one of the critical steps toward tumorigenesis (Thompson, 1995; Naik et al., 1996) . In this context, oncogenes are involved not only in stimulating proliferation but also in promoting survival during multistep tumorigenesis. TGF-b is highly expressed in cirrhotic liver, a disease background where hepatocellular carcinoma often develop (Tanaka and Wands, 1996) . Escape from TGF-b-induced apoptosis is likely to be one of the mechanisms leading to liver tumorigenesis. Indeed, several lines of evidence suggest that growth factors that activate the PI 3-kinase/Akt pathway play an important role in hepatic carcinogenesis in vivo. Elevated expression of insulin-like growth factors (IGFs) has frequently occurred in hepatoma cells of many species (Cariani et al., 1988; Takagi et al., 1992; Yang et al., 1993) . During hepatitis virusmediated liver oncogenesis in animal, IGF II and Nmyc are both overexpressed at an early stage (Yang et al., 1993) . Furthermore, IGF II is capable of protecting hepatocytes from apoptosis induced by N-myc (Ueda and Ganem, 1996) . Thus, the PI 3-kinase/Akt pathway may be considered as a therapeutic target for treatment of hepatocellular carcinoma.
Materials and methods
Cells, antibodies and reagents
Hep3B human hepatoma cells were cultured as described previously (Chen and Chang, 1997) . The antibodies against PI 3-kinase p110a and H-Ras were purchased from Santa Cruz Biotechnology and Transduction Laboratories, respectively. The anti-HA and anti-Flag antibodies were from Boehringer Mannheim and IBI, respectively. The anti-myc antibody was kindly provided by R Derynck. LY294002, rapamycin and PD98059 were obtained from Calbiochem.
Plasmids
Plasmid pZIP-v-H-Ras for expressing v-H-Ras together with the neomycin resistant gene was a gift from Dr CJ Der. Mammalian expression vectors for the constitutively active form of PI 3-kinase (p110*) (Hu et al., 1995) and the myristoylated and kinase-dead forms of Akt (K179A) (Kulik et al., 1997) were kindly provided by Dr A Klippel. Expression vector for the Flag-tagged Smad4 (pRKSmad4F) (Zhang et al., 1996) was a generous gift from Dr R Derynck. pCDNA3-M-Smad3 for expression of the myc-tagged Smad3 was constructed by replacing the Flag epitope tag from pCDNA3-F-Smad3 (Nakao et al., 1997) (obtained from Dr M Kawabata) with a myc epitope tag (GEQKLISEEDLN). Expression plasmids for the His-tagged type I and untagged type II TGF-b receptors were kindly provided by Dr J MassagueÂ and previously described (Chen et al., 1993) , respectively.
Transfection
Expression vectors were transfected alone or cotransfected with the plasmid pSVneo into Hep3B cells using LipofectAmine reagent (Life Technologies) according to the manufacturer's instructions. For transient transfection, the cells were harvested at 48 h after transfection. For selection of stable clones, G418 (700 mg/ml) was added into culture medium at 48 h after transfection. The G418 resistant clones were individually picked, expanded and then assayed for their expression of transfected cDNAs by Western blotting.
Apoptosis assays
For TUNEL assays (Gavrieli et al., 1992) , cells seeded on chamber slides were serum starved for 24 h and then treated with or without TGF-b (5 ng/ml) for 18 h. Cells were ®xed with 4% paraformaldehyde, and then permeabilized with 0.1% Triton X-100 and 0.1% sodium citrate. TUNEL assays were performed using the In Situ Death Detection Kit, Fluorescein (Boehringer Mannheim) according to the manufacturer's instructions. Apoptotic cells were visualized by¯uorescence microscopy.
Apoptosis was also quantitated by Cell-Death Detection ELISA assays (Thome et al., 1997 ) (Boehringer Mannheim), which measures the presence of soluble histone-DNA complex as a result of DNA fragmentation. Cells were seeded onto 96-well plates at a density of 0.5610 4 cells/well. After serum starvation for 24 h, the cells were treated with or without TGF-b (5 ng/ml), insulin (10 77 M) and various signaling blockers. The cells were harvested 18 h later and assayed for apoptosis according to the manufacturer's instructions.
Thymidine incorporation
Cells were seeded onto 48-well plates at a density of 2610 4 cells/well. After serum starvation for 24 h, DNA synthesis was measured by incubating cells in culture medium without serum but containing 5 mCi/ml [ 3 H]thymidine for 16 h.
Immunoprecipitation followed by Western blotting
Cells were transiently transfected with various constructs and treated with or without TGF-b at 48 h after transfection. The cells were harvested 1 h later in lysis buer containing 20 mM Tris (pH 7.5), 137 mM NaCl, 0.5% NP40, 1 mM PMSF, 10 mg/ml aprotinin and 10 mg/ml leupeptin. Immunoprecipitations using antibodies to myc and Flag were described previously (Chen and Derynck, 1994) . Following immunoprecipitations, the immunocomplexes were eluted by boiling for 3 min in SDS sample buer (100 mM Tris, pH 6.8, 36% glycerol, 4% SDS, 0.01% boromophenol blue and 200 mM DTT) and subjected to SDS ± PAGE. Proteins were then transferred to nitrocellulose membrane and immunoblotted with the anti-Flag antibody and developed using an enhanced chemiluminescence detection system.
Immuno¯uorescent and nuclear staining
Cells were transiently transfected with plasmids expressing type I, type II TGF-b receptors, myc-Smad3 and Smad4-Flag. After transfection, the cells were seeded on chamber slides and allowed to adhere overnight. The cells were serum starved for 24 h and then treated with or without TGF-b for 1 h. Immediately after treatment, the cells were rinsed once with phosphate-buered saline (PBS), ®xed in 4% paraformaldehyde in PBS for 15 min and permeabilized with 0.2% Triton X-100 in PBS for 5 min. The cells were blocked in 3% BSA and stained with the anti-Flag or anti-myc antibody followed by a goat anti-mouse antibody labeled with Texas red (Amersham). The cells were then stained with Hoechst 33258 (5 mg/ml) in PBS for examining the nuclear morphology.
In vitro assay for caspase-3-like activities Cells were seeded onto 6-well plates, serum starved for 24 h, and treated with or without TGF-b (5 ng/ml) and insulin (10 77 M) for various times. Cells were lyzed in RIPA buer containing 50 mM Tris (pH 8.0), 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 10 mg/ml leupeptin and 10 mg/ml aprotinin and cell lysates were centrifuged at 14 000 r.p.m. The supernatants were assayed for protein concentrations. Cell lysate with 100 mg proteins in 1 ml assay buer containing 50 mM Tris-HCl (pH 7.4), 1 mM EDTA and 1 mM EGTA was incubated with a¯uorogenic peptide substrate, Ac-DEVD-AMC (5.6 mM) at 378C for 30 min. Fluorescence was quanti®ed in a spectro¯uorometer (excitation 380 nm, emission 460 nm).
